Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer.

Shen, Qian; Li, Junchen; Zhang, Chuanlong; Pan, Xue; Li, Yi; Zhang, Xiyuan; En, Ge'er; Pang, Bo

Shen, Qian; Li, Junchen; Zhang, Chuanlong; Pan, Xue; Li, Yi; Zhang, Xiyuan; En, Ge'er; Pang, Bo.

Afiliação

Shen Q; Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Li J; Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Zhang C; Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Pan X; Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Li Y; Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Zhang X; Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
En G; Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Pang B; Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Aging (Albany NY) ; 15(18): 9779-9796, 2023 09 20.

Article em En | MEDLINE | ID: mdl-37733696

Assuntos

Neoplasias Pancreáticas; Humanos; Prognóstico; Neoplasias Pancreáticas/tratamento farmacológico; Neoplasias Pancreáticas/genética; Biomarcadores; Oncologia; Microambiente Tumoral/genética; Neoplasias Pancreáticas

Palavras-chave

NDC1; immune; pan-cancer; pancreatic cancer; prognosis; therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas Idioma: En Ano de publicação: 2023 Tipo de documento: Article